A detailed history of Brevan Howard Capital Management LP transactions in Quest Diagnostics Inc stock. As of the latest transaction made, Brevan Howard Capital Management LP holds 4,647 shares of DGX stock, worth $637,057. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,647
Previous 5,771 19.48%
Holding current value
$637,057
Previous $789,000 19.26%
% of portfolio
0.0%
Previous 0.01%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$137.09 - $137.09 $154,089 - $154,089
-1,124 Reduced 19.48%
4,647 $637,000
Q2 2024

Aug 14, 2024

BUY
$125.91 - $144.34 $258,870 - $296,763
2,056 Added 55.34%
5,771 $789,000
Q1 2024

May 15, 2024

BUY
$123.78 - $142.11 $459,842 - $527,938
3,715 New
3,715 $494,000

Others Institutions Holding DGX

About QUEST DIAGNOSTICS INC


  • Ticker DGX
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 113,887,000
  • Market Cap $15.6B
  • Description
  • Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers dia...
More about DGX
Track This Portfolio

Track Brevan Howard Capital Management LP Portfolio

Follow Brevan Howard Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Brevan Howard Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Brevan Howard Capital Management LP with notifications on news.